 Eric Simoes
Concepts (459)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Respiratory Syncytial Virus Infections | 40 | 2018 | 119 | 5.700 |
Why?
| | Respiratory Syncytial Viruses | 18 | 2017 | 52 | 1.790 |
Why?
| | Respiratory Syncytial Virus, Human | 12 | 2018 | 68 | 1.300 |
Why?
| | Hospitalization | 19 | 2021 | 2057 | 0.960 |
Why?
| | Antibodies, Viral | 16 | 2025 | 601 | 0.920 |
Why?
| | Influenza, Human | 4 | 2024 | 601 | 0.860 |
Why?
| | Antibodies, Monoclonal | 9 | 2007 | 1355 | 0.850 |
Why?
| | Immunoglobulins, Intravenous | 9 | 2002 | 130 | 0.770 |
Why?
| | Macaca radiata | 8 | 2003 | 15 | 0.750 |
Why?
| | Respiratory Tract Infections | 11 | 2017 | 372 | 0.740 |
Why?
| | Otoscopes | 1 | 2021 | 4 | 0.730 |
Why?
| | Infant | 59 | 2024 | 8914 | 0.720 |
Why?
| | Pneumococcal Vaccines | 2 | 2021 | 139 | 0.670 |
Why?
| | Seasons | 9 | 2021 | 497 | 0.660 |
Why?
| | Bronchiolitis, Viral | 4 | 2013 | 11 | 0.620 |
Why?
| | Antiviral Agents | 5 | 2007 | 703 | 0.620 |
Why?
| | Respiratory Syncytial Virus Vaccines | 4 | 2013 | 34 | 0.600 |
Why?
| | Suicide | 1 | 2023 | 578 | 0.530 |
Why?
| | Infant, Premature | 10 | 2007 | 535 | 0.510 |
Why?
| | Child, Preschool | 43 | 2024 | 10384 | 0.500 |
Why?
| | Poliovirus | 5 | 2001 | 82 | 0.480 |
Why?
| | India | 12 | 2024 | 170 | 0.480 |
Why?
| | Infant, Newborn | 33 | 2025 | 5687 | 0.460 |
Why?
| | Developing Countries | 11 | 2024 | 285 | 0.460 |
Why?
| | Measles | 2 | 2025 | 44 | 0.410 |
Why?
| | Infant, Premature, Diseases | 4 | 2002 | 93 | 0.410 |
Why?
| | Pneumonia | 10 | 2011 | 598 | 0.400 |
Why?
| | Palivizumab | 8 | 2007 | 13 | 0.400 |
Why?
| | Population Surveillance | 4 | 2024 | 427 | 0.390 |
Why?
| | Incidence | 10 | 2024 | 2616 | 0.390 |
Why?
| | Immunoglobulins | 3 | 2002 | 157 | 0.370 |
Why?
| | Viral Vaccines | 4 | 2005 | 94 | 0.370 |
Why?
| | Humans | 95 | 2025 | 128418 | 0.360 |
Why?
| | Prospective Studies | 17 | 2024 | 7036 | 0.350 |
Why?
| | Respiratory Sounds | 4 | 2013 | 120 | 0.340 |
Why?
| | Bronchiolitis | 6 | 1999 | 87 | 0.330 |
Why?
| | Virus Diseases | 3 | 2015 | 209 | 0.330 |
Why?
| | Child | 26 | 2024 | 20655 | 0.320 |
Why?
| | Pneumococcal Infections | 2 | 2008 | 110 | 0.310 |
Why?
| | Heart Defects, Congenital | 6 | 2005 | 740 | 0.300 |
Why?
| | Streptococcal Infections | 2 | 2024 | 144 | 0.300 |
Why?
| | Disease Outbreaks | 4 | 2021 | 341 | 0.300 |
Why?
| | Immunization, Passive | 4 | 2002 | 85 | 0.290 |
Why?
| | Carotid Artery Thrombosis | 1 | 2007 | 7 | 0.280 |
Why?
| | Pregnancy Complications, Infectious | 2 | 2024 | 364 | 0.280 |
Why?
| | Spinal Cord | 2 | 2001 | 353 | 0.280 |
Why?
| | Cavernous Sinus Thrombosis | 1 | 2007 | 9 | 0.280 |
Why?
| | Philippines | 7 | 2021 | 49 | 0.280 |
Why?
| | Mucormycosis | 1 | 2007 | 21 | 0.280 |
Why?
| | Antibodies, Monoclonal, Humanized | 9 | 2007 | 755 | 0.280 |
Why?
| | Paranasal Sinus Diseases | 1 | 2007 | 15 | 0.280 |
Why?
| | Carotid Artery, Internal | 1 | 2007 | 41 | 0.280 |
Why?
| | Orbital Diseases | 1 | 2007 | 28 | 0.270 |
Why?
| | Female | 43 | 2025 | 68154 | 0.270 |
Why?
| | Poliovirus Vaccine, Inactivated | 4 | 1988 | 28 | 0.260 |
Why?
| | Antifungal Agents | 1 | 2007 | 122 | 0.260 |
Why?
| | Autopsy | 2 | 2023 | 92 | 0.260 |
Why?
| | Vaccines, Attenuated | 4 | 2001 | 126 | 0.260 |
Why?
| | Indonesia | 2 | 2024 | 21 | 0.250 |
Why?
| | Triazoles | 1 | 2007 | 147 | 0.250 |
Why?
| | Pneumonia, Viral | 5 | 2000 | 341 | 0.250 |
Why?
| | Sex Work | 3 | 1993 | 20 | 0.240 |
Why?
| | Male | 38 | 2025 | 62858 | 0.240 |
Why?
| | Asthma | 4 | 2002 | 2213 | 0.240 |
Why?
| | Bronchopulmonary Dysplasia | 6 | 1998 | 375 | 0.240 |
Why?
| | Child, Hospitalized | 1 | 2005 | 48 | 0.230 |
Why?
| | Immunoglobulin G | 3 | 2025 | 843 | 0.230 |
Why?
| | Community-Acquired Infections | 3 | 2015 | 152 | 0.230 |
Why?
| | Child Health Services | 2 | 2003 | 185 | 0.220 |
Why?
| | Metapneumovirus | 2 | 2013 | 13 | 0.210 |
Why?
| | Streptococcus agalactiae | 1 | 2024 | 93 | 0.210 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2024 | 146 | 0.210 |
Why?
| | Leukotriene Antagonists | 1 | 2003 | 43 | 0.210 |
Why?
| | Measles Vaccine | 3 | 2025 | 20 | 0.200 |
Why?
| | Infectious Disease Transmission, Vertical | 1 | 2024 | 170 | 0.200 |
Why?
| | Severity of Illness Index | 7 | 2008 | 2722 | 0.200 |
Why?
| | Longitudinal Studies | 5 | 2023 | 2710 | 0.200 |
Why?
| | Acetates | 1 | 2003 | 97 | 0.200 |
Why?
| | Bronchial Provocation Tests | 1 | 2002 | 50 | 0.200 |
Why?
| | Poliomyelitis | 2 | 2001 | 36 | 0.200 |
Why?
| | Developed Countries | 1 | 2002 | 33 | 0.200 |
Why?
| | Cross Infection | 2 | 2013 | 195 | 0.190 |
Why?
| | Quinolines | 1 | 2003 | 153 | 0.190 |
Why?
| | Risk Factors | 17 | 2017 | 9704 | 0.190 |
Why?
| | Adult | 16 | 2025 | 35300 | 0.190 |
Why?
| | Altitude | 1 | 2006 | 447 | 0.190 |
Why?
| | Disease Models, Animal | 5 | 2003 | 3937 | 0.190 |
Why?
| | Cause of Death | 1 | 2023 | 393 | 0.180 |
Why?
| | Poliovirus Vaccine, Oral | 1 | 2001 | 25 | 0.180 |
Why?
| | Otoscopy | 1 | 2021 | 8 | 0.180 |
Why?
| | Length of Stay | 4 | 2005 | 1113 | 0.180 |
Why?
| | Young Adult | 5 | 2025 | 12312 | 0.180 |
Why?
| | Adolescent | 9 | 2025 | 20179 | 0.180 |
Why?
| | Peripheral Nerves | 1 | 2001 | 66 | 0.180 |
Why?
| | Mothers | 2 | 2005 | 729 | 0.180 |
Why?
| | Hospital Charges | 1 | 2000 | 41 | 0.170 |
Why?
| | Denmark | 3 | 2009 | 44 | 0.170 |
Why?
| | Environmental Exposure | 1 | 2003 | 461 | 0.160 |
Why?
| | Diphtheria Toxoid | 3 | 1988 | 12 | 0.160 |
Why?
| | Pertussis Vaccine | 3 | 1988 | 21 | 0.160 |
Why?
| | Tetanus Toxoid | 3 | 1988 | 37 | 0.160 |
Why?
| | Parvovirus B19, Human | 1 | 2018 | 3 | 0.150 |
Why?
| | Colorado | 4 | 2021 | 4375 | 0.150 |
Why?
| | Parvoviridae Infections | 1 | 2018 | 11 | 0.150 |
Why?
| | HN Protein | 1 | 1998 | 5 | 0.150 |
Why?
| | Cost of Illness | 1 | 2000 | 277 | 0.150 |
Why?
| | Anxiety | 1 | 2005 | 955 | 0.150 |
Why?
| | Respiratory Tract Diseases | 1 | 1999 | 150 | 0.150 |
Why?
| | Virus Replication | 4 | 2003 | 444 | 0.150 |
Why?
| | Referral and Consultation | 1 | 2003 | 727 | 0.150 |
Why?
| | Caregivers | 1 | 2005 | 810 | 0.140 |
Why?
| | Rickets | 1 | 1997 | 9 | 0.140 |
Why?
| | Viral Proteins | 2 | 1998 | 321 | 0.140 |
Why?
| | Air | 1 | 1997 | 36 | 0.140 |
Why?
| | Lung Diseases | 1 | 2003 | 715 | 0.140 |
Why?
| | RNA, Viral | 3 | 2001 | 616 | 0.140 |
Why?
| | Ventilator Weaning | 1 | 1997 | 35 | 0.140 |
Why?
| | Stress, Psychological | 1 | 2005 | 1060 | 0.130 |
Why?
| | Education, Nursing, Continuing | 1 | 1997 | 48 | 0.130 |
Why?
| | Acquired Immunodeficiency Syndrome | 2 | 1987 | 222 | 0.120 |
Why?
| | Neutralization Tests | 3 | 2001 | 73 | 0.120 |
Why?
| | Pharyngeal Diseases | 1 | 1995 | 14 | 0.120 |
Why?
| | Postpartum Period | 1 | 2018 | 330 | 0.120 |
Why?
| | In Situ Hybridization | 3 | 2001 | 292 | 0.120 |
Why?
| | Jugular Veins | 1 | 1995 | 39 | 0.120 |
Why?
| | Mouth | 1 | 1995 | 80 | 0.120 |
Why?
| | Haemophilus Infections | 1 | 1995 | 38 | 0.120 |
Why?
| | Abscess | 1 | 1995 | 73 | 0.110 |
Why?
| | Africa South of the Sahara | 2 | 2025 | 41 | 0.110 |
Why?
| | Double-Blind Method | 8 | 2007 | 1848 | 0.110 |
Why?
| | Cerebral Aqueduct | 1 | 1994 | 4 | 0.110 |
Why?
| | Infectious Mononucleosis | 1 | 1994 | 9 | 0.110 |
Why?
| | Respirovirus Infections | 2 | 1993 | 23 | 0.110 |
Why?
| | Otitis Media | 1 | 1996 | 160 | 0.110 |
Why?
| | Gestational Age | 3 | 2005 | 867 | 0.110 |
Why?
| | Nucleoproteins | 1 | 2013 | 28 | 0.110 |
Why?
| | HIV Infections | 3 | 2018 | 2701 | 0.110 |
Why?
| | Pregnancy | 5 | 2025 | 6357 | 0.110 |
Why?
| | Human bocavirus | 1 | 2013 | 1 | 0.110 |
Why?
| | Triplets | 1 | 1993 | 2 | 0.110 |
Why?
| | Models, Statistical | 1 | 2017 | 621 | 0.110 |
Why?
| | HIV Antibodies | 1 | 1993 | 57 | 0.110 |
Why?
| | South Africa | 3 | 2024 | 192 | 0.100 |
Why?
| | Oropharynx | 1 | 2013 | 42 | 0.100 |
Why?
| | Primary Health Care | 1 | 2003 | 1670 | 0.100 |
Why?
| | Disease Management | 1 | 1997 | 587 | 0.100 |
Why?
| | Hydrocephalus | 1 | 1994 | 108 | 0.100 |
Why?
| | Pediatric Nursing | 1 | 1992 | 39 | 0.100 |
Why?
| | Cohort Studies | 4 | 2018 | 5388 | 0.100 |
Why?
| | Community Health Workers | 1 | 1992 | 50 | 0.100 |
Why?
| | Vaccines, Inactivated | 2 | 2003 | 69 | 0.100 |
Why?
| | Encephalitis | 1 | 1994 | 132 | 0.100 |
Why?
| | Case-Control Studies | 5 | 2018 | 3328 | 0.100 |
Why?
| | Diseases in Twins | 1 | 1993 | 176 | 0.100 |
Why?
| | Respiratory Physiological Phenomena | 1 | 1991 | 30 | 0.090 |
Why?
| | Europe | 2 | 2003 | 359 | 0.090 |
Why?
| | Respiratory Function Tests | 3 | 2002 | 580 | 0.090 |
Why?
| | Pneumonia, Bacterial | 2 | 2009 | 109 | 0.090 |
Why?
| | Aged | 5 | 2024 | 21953 | 0.090 |
Why?
| | Thrombosis | 1 | 1995 | 324 | 0.090 |
Why?
| | Ulnar Nerve | 2 | 2001 | 16 | 0.090 |
Why?
| | Age Distribution | 4 | 2007 | 371 | 0.090 |
Why?
| | Genes, Viral | 1 | 1991 | 81 | 0.090 |
Why?
| | Breast Feeding | 2 | 2003 | 422 | 0.090 |
Why?
| | Retrospective Studies | 6 | 2023 | 14454 | 0.090 |
Why?
| | Time Factors | 7 | 2018 | 6482 | 0.090 |
Why?
| | Socioeconomic Factors | 2 | 2006 | 1212 | 0.090 |
Why?
| | Sequence Analysis, DNA | 1 | 2013 | 771 | 0.090 |
Why?
| | Middle Aged | 5 | 2024 | 30889 | 0.080 |
Why?
| | Clinical Competence | 1 | 1997 | 1013 | 0.080 |
Why?
| | Measles virus | 2 | 2025 | 13 | 0.080 |
Why?
| | Lung | 2 | 2001 | 3743 | 0.080 |
Why?
| | Logistic Models | 4 | 2009 | 1974 | 0.080 |
Why?
| | Algorithms | 3 | 2009 | 1618 | 0.080 |
Why?
| | Sensitivity and Specificity | 5 | 2007 | 1815 | 0.080 |
Why?
| | Protein Biosynthesis | 1 | 1991 | 397 | 0.080 |
Why?
| | Animals | 10 | 2004 | 34479 | 0.080 |
Why?
| | Single-Blind Method | 3 | 1998 | 267 | 0.070 |
Why?
| | Mozambique | 2 | 2024 | 6 | 0.070 |
Why?
| | Global Health | 2 | 2017 | 327 | 0.070 |
Why?
| | Maternal-Fetal Exchange | 1 | 2009 | 161 | 0.070 |
Why?
| | Respiration | 3 | 1997 | 190 | 0.070 |
Why?
| | Mucor | 1 | 2007 | 7 | 0.070 |
Why?
| | HIV-1 | 1 | 1993 | 836 | 0.070 |
Why?
| | Ethiopia | 2 | 1997 | 35 | 0.070 |
Why?
| | United States | 6 | 2007 | 13830 | 0.070 |
Why?
| | Debridement | 1 | 2007 | 86 | 0.070 |
Why?
| | Prevalence | 2 | 2024 | 2547 | 0.070 |
Why?
| | Central Nervous System Bacterial Infections | 1 | 2006 | 5 | 0.070 |
Why?
| | Meningitis, Bacterial | 1 | 2007 | 46 | 0.070 |
Why?
| | Weather | 1 | 2007 | 34 | 0.070 |
Why?
| | Reference Values | 2 | 2007 | 776 | 0.070 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2007 | 43 | 0.070 |
Why?
| | Probability | 1 | 2007 | 305 | 0.070 |
Why?
| | Cell Line | 3 | 2004 | 2731 | 0.070 |
Why?
| | Rectum | 2 | 2024 | 169 | 0.070 |
Why?
| | Deltaretrovirus | 1 | 1985 | 12 | 0.060 |
Why?
| | Secondary Prevention | 1 | 2007 | 219 | 0.060 |
Why?
| | Predictive Value of Tests | 5 | 2009 | 1935 | 0.060 |
Why?
| | Convalescence | 1 | 2005 | 18 | 0.060 |
Why?
| | Asia, Southeastern | 1 | 2025 | 11 | 0.060 |
Why?
| | Biomedical Research | 1 | 2011 | 635 | 0.060 |
Why?
| | DNA, Bacterial | 1 | 2007 | 323 | 0.060 |
Why?
| | Immunity, Maternally-Acquired | 1 | 2025 | 18 | 0.060 |
Why?
| | Drug Administration Schedule | 1 | 2007 | 751 | 0.060 |
Why?
| | Athetosis | 1 | 2005 | 7 | 0.060 |
Why?
| | Chorea | 1 | 2005 | 11 | 0.060 |
Why?
| | Pediatrics | 3 | 2001 | 1046 | 0.060 |
Why?
| | Cyanosis | 2 | 2009 | 16 | 0.060 |
Why?
| | Antibodies, Bacterial | 2 | 2000 | 135 | 0.060 |
Why?
| | Bhutan | 1 | 2024 | 3 | 0.060 |
Why?
| | Seroepidemiologic Studies | 1 | 2025 | 155 | 0.060 |
Why?
| | Blood Donors | 1 | 1985 | 96 | 0.060 |
Why?
| | Asia | 1 | 2024 | 57 | 0.060 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2007 | 756 | 0.060 |
Why?
| | Paramyxoviridae | 1 | 2004 | 2 | 0.060 |
Why?
| | Paramyxoviridae Infections | 1 | 2004 | 11 | 0.060 |
Why?
| | Africa | 1 | 2024 | 98 | 0.060 |
Why?
| | Maxillary Sinus | 1 | 2004 | 11 | 0.060 |
Why?
| | Maxillary Sinusitis | 1 | 2004 | 7 | 0.060 |
Why?
| | Sinusitis | 2 | 1999 | 202 | 0.060 |
Why?
| | Family Health | 1 | 2005 | 196 | 0.060 |
Why?
| | Hypothermia, Induced | 1 | 2005 | 72 | 0.050 |
Why?
| | Orthomyxoviridae | 1 | 2004 | 40 | 0.050 |
Why?
| | Orthomyxoviridae Infections | 1 | 2004 | 67 | 0.050 |
Why?
| | Data Interpretation, Statistical | 1 | 2005 | 335 | 0.050 |
Why?
| | Multivariate Analysis | 1 | 2007 | 1484 | 0.050 |
Why?
| | Equipment and Supplies | 1 | 2003 | 41 | 0.050 |
Why?
| | U937 Cells | 1 | 2003 | 23 | 0.050 |
Why?
| | Blood Transfusion | 1 | 1985 | 290 | 0.050 |
Why?
| | Disease Susceptibility | 1 | 2005 | 331 | 0.050 |
Why?
| | Nasal Mucosa | 1 | 2004 | 107 | 0.050 |
Why?
| | Acute Disease | 3 | 2013 | 964 | 0.050 |
Why?
| | Spain | 1 | 2003 | 35 | 0.050 |
Why?
| | Steroids | 2 | 2001 | 147 | 0.050 |
Why?
| | Diphtheria-Tetanus-Pertussis Vaccine | 3 | 1988 | 25 | 0.050 |
Why?
| | Cyclopropanes | 1 | 2003 | 88 | 0.050 |
Why?
| | Cell Count | 2 | 2004 | 313 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2007 | 1936 | 0.050 |
Why?
| | Demography | 1 | 2003 | 277 | 0.050 |
Why?
| | Odds Ratio | 2 | 1997 | 1023 | 0.050 |
Why?
| | Malnutrition | 1 | 2003 | 79 | 0.050 |
Why?
| | Climate | 1 | 2003 | 87 | 0.050 |
Why?
| | Vagina | 1 | 2024 | 175 | 0.050 |
Why?
| | Geography | 1 | 2003 | 186 | 0.050 |
Why?
| | Sulfides | 1 | 2003 | 94 | 0.050 |
Why?
| | Rhinitis | 1 | 2004 | 148 | 0.050 |
Why?
| | Intensive Care Units, Neonatal | 2 | 1997 | 221 | 0.050 |
Why?
| | Japan | 1 | 2002 | 96 | 0.050 |
Why?
| | Phylogeny | 2 | 2018 | 838 | 0.050 |
Why?
| | Morbidity | 1 | 2003 | 301 | 0.050 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2002 | 136 | 0.050 |
Why?
| | Drug Combinations | 3 | 1988 | 323 | 0.050 |
Why?
| | Treatment Outcome | 7 | 2007 | 10152 | 0.050 |
Why?
| | Vaccines, Synthetic | 1 | 2002 | 126 | 0.050 |
Why?
| | Body Weight | 1 | 1986 | 928 | 0.050 |
Why?
| | Vaccines, Subunit | 1 | 2001 | 47 | 0.050 |
Why?
| | Formaldehyde | 1 | 2001 | 57 | 0.050 |
Why?
| | Follow-Up Studies | 3 | 2007 | 4892 | 0.050 |
Why?
| | Administration, Inhalation | 2 | 2001 | 661 | 0.050 |
Why?
| | Hospitals, District | 1 | 2001 | 6 | 0.050 |
Why?
| | Virus Shedding | 1 | 2001 | 45 | 0.050 |
Why?
| | Canada | 1 | 2002 | 344 | 0.040 |
Why?
| | Models, Immunological | 1 | 2001 | 93 | 0.040 |
Why?
| | Mortality | 1 | 2003 | 307 | 0.040 |
Why?
| | Poverty | 1 | 2024 | 496 | 0.040 |
Why?
| | Health Services Research | 1 | 2003 | 391 | 0.040 |
Why?
| | Macaca | 1 | 1980 | 50 | 0.040 |
Why?
| | Nerve Fibers, Myelinated | 1 | 1980 | 43 | 0.040 |
Why?
| | Serum Albumin | 1 | 2001 | 145 | 0.040 |
Why?
| | Hospitals, Teaching | 1 | 2001 | 112 | 0.040 |
Why?
| | Oxygen | 1 | 2005 | 899 | 0.040 |
Why?
| | Viremia | 1 | 2001 | 130 | 0.040 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2000 | 815 | 0.040 |
Why?
| | Anti-Inflammatory Agents | 2 | 2001 | 468 | 0.040 |
Why?
| | Bacteria | 1 | 2007 | 808 | 0.040 |
Why?
| | Influenza B virus | 2 | 2004 | 37 | 0.040 |
Why?
| | Neuroglia | 1 | 2001 | 166 | 0.040 |
Why?
| | Nasopharynx | 2 | 1998 | 67 | 0.040 |
Why?
| | Tobacco Smoke Pollution | 1 | 2003 | 229 | 0.040 |
Why?
| | Wrist | 1 | 1980 | 52 | 0.040 |
Why?
| | Cross-Sectional Studies | 3 | 2018 | 5039 | 0.040 |
Why?
| | Intensive Care Units, Pediatric | 2 | 1998 | 200 | 0.040 |
Why?
| | BCG Vaccine | 1 | 1999 | 24 | 0.040 |
Why?
| | Sex Factors | 2 | 2003 | 1945 | 0.040 |
Why?
| | Cardiac Surgical Procedures | 1 | 2005 | 490 | 0.040 |
Why?
| | Influenza A virus | 2 | 2004 | 101 | 0.040 |
Why?
| | AIDS-Related Opportunistic Infections | 1 | 2000 | 121 | 0.040 |
Why?
| | Age Factors | 4 | 2006 | 3103 | 0.040 |
Why?
| | Injections, Intravenous | 1 | 1999 | 190 | 0.040 |
Why?
| | Fever | 2 | 2018 | 295 | 0.040 |
Why?
| | Hand | 1 | 1980 | 152 | 0.040 |
Why?
| | Patient Discharge | 1 | 2005 | 853 | 0.040 |
Why?
| | Hospital Mortality | 2 | 2017 | 844 | 0.040 |
Why?
| | Antigens, Viral | 1 | 1999 | 174 | 0.040 |
Why?
| | Parvovirus | 1 | 2018 | 13 | 0.040 |
Why?
| | Vaccination | 2 | 2001 | 1346 | 0.040 |
Why?
| | Risk Assessment | 1 | 2007 | 3232 | 0.040 |
Why?
| | Intensive Care Units | 1 | 2003 | 717 | 0.040 |
Why?
| | Research | 1 | 2001 | 411 | 0.040 |
Why?
| | Fluorescent Antibody Technique | 1 | 1998 | 371 | 0.040 |
Why?
| | Vaccines, Combined | 2 | 1988 | 48 | 0.040 |
Why?
| | Nutrition Disorders | 1 | 1997 | 23 | 0.030 |
Why?
| | Viral Envelope Proteins | 1 | 1998 | 80 | 0.030 |
Why?
| | Practice Guidelines as Topic | 2 | 2009 | 1478 | 0.030 |
Why?
| | Bacterial Infections | 2 | 2007 | 226 | 0.030 |
Why?
| | Child Nutrition Disorders | 1 | 1997 | 19 | 0.030 |
Why?
| | World Health Organization | 2 | 2008 | 110 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2000 | 568 | 0.030 |
Why?
| | Animals, Newborn | 1 | 1999 | 803 | 0.030 |
Why?
| | Nursing Assessment | 1 | 1997 | 52 | 0.030 |
Why?
| | Neutrophils | 1 | 2002 | 1193 | 0.030 |
Why?
| | Dehydration | 1 | 1997 | 50 | 0.030 |
Why?
| | Pulmonary Alveoli | 1 | 1999 | 366 | 0.030 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 1999 | 626 | 0.030 |
Why?
| | Birth Weight | 2 | 1993 | 498 | 0.030 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 1997 | 104 | 0.030 |
Why?
| | Health Services Accessibility | 1 | 2003 | 896 | 0.030 |
Why?
| | Macrophages, Alveolar | 1 | 1999 | 376 | 0.030 |
Why?
| | Quality of Health Care | 1 | 2001 | 606 | 0.030 |
Why?
| | DNA, Viral | 1 | 2018 | 348 | 0.030 |
Why?
| | Oxygen Inhalation Therapy | 1 | 1997 | 141 | 0.030 |
Why?
| | Comorbidity | 1 | 2000 | 1543 | 0.030 |
Why?
| | Bangladesh | 1 | 2015 | 45 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 1 | 2007 | 3376 | 0.030 |
Why?
| | Lung Abscess | 1 | 1995 | 7 | 0.030 |
Why?
| | Epidemiological Monitoring | 1 | 2015 | 49 | 0.030 |
Why?
| | Nasal Cavity | 1 | 2015 | 50 | 0.030 |
Why?
| | Blood | 1 | 2015 | 99 | 0.030 |
Why?
| | Cerebrospinal Fluid | 1 | 2015 | 88 | 0.030 |
Why?
| | Nutritional Status | 1 | 1997 | 325 | 0.030 |
Why?
| | Prognosis | 1 | 2003 | 3772 | 0.030 |
Why?
| | Fruit | 1 | 1995 | 131 | 0.030 |
Why?
| | Ventriculoperitoneal Shunt | 1 | 1994 | 37 | 0.030 |
Why?
| | Eating | 2 | 1999 | 368 | 0.030 |
Why?
| | Oxygen Consumption | 1 | 1997 | 669 | 0.030 |
Why?
| | Vegetables | 1 | 1995 | 147 | 0.030 |
Why?
| | Ribavirin | 1 | 1994 | 91 | 0.030 |
Why?
| | Opportunistic Infections | 1 | 1993 | 46 | 0.030 |
Why?
| | Counseling | 1 | 1997 | 382 | 0.030 |
Why?
| | Constriction, Pathologic | 1 | 1994 | 228 | 0.030 |
Why?
| | Herpesvirus 4, Human | 1 | 1994 | 151 | 0.030 |
Why?
| | Crowding | 1 | 1993 | 35 | 0.030 |
Why?
| | Influenza Vaccines | 1 | 1998 | 536 | 0.030 |
Why?
| | Neurons | 1 | 2001 | 1448 | 0.030 |
Why?
| | Hospitals, University | 1 | 1993 | 176 | 0.030 |
Why?
| | Respiration, Artificial | 1 | 1997 | 598 | 0.020 |
Why?
| | Radiography | 3 | 2008 | 859 | 0.020 |
Why?
| | Methods | 1 | 1991 | 64 | 0.020 |
Why?
| | Sexual Partners | 1 | 1993 | 185 | 0.020 |
Why?
| | RNA, Messenger | 1 | 1999 | 2675 | 0.020 |
Why?
| | Rural Population | 1 | 2015 | 511 | 0.020 |
Why?
| | Cell Transformation, Viral | 1 | 1991 | 27 | 0.020 |
Why?
| | Psychomotor Agitation | 1 | 1991 | 64 | 0.020 |
Why?
| | Immunocompromised Host | 1 | 2013 | 194 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 940 | 0.020 |
Why?
| | Inflammation | 1 | 2001 | 2654 | 0.020 |
Why?
| | Mutagenesis, Site-Directed | 1 | 1991 | 358 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 1991 | 522 | 0.020 |
Why?
| | Rural Health | 1 | 2009 | 70 | 0.020 |
Why?
| | Hospitals, Pediatric | 1 | 1993 | 505 | 0.020 |
Why?
| | Typhoid-Paratyphoid Vaccines | 1 | 1989 | 4 | 0.020 |
Why?
| | HeLa Cells | 1 | 1991 | 603 | 0.020 |
Why?
| | Salmonella typhi | 1 | 1989 | 13 | 0.020 |
Why?
| | Typhoid Fever | 1 | 1989 | 10 | 0.020 |
Why?
| | Sexual Behavior | 1 | 1993 | 481 | 0.020 |
Why?
| | Transfection | 1 | 1991 | 893 | 0.020 |
Why?
| | Genetic Variation | 1 | 2013 | 933 | 0.020 |
Why?
| | Nucleic Acid Conformation | 1 | 1991 | 706 | 0.020 |
Why?
| | Meteorological Concepts | 1 | 2007 | 6 | 0.020 |
Why?
| | Kinetics | 1 | 1991 | 1615 | 0.020 |
Why?
| | Buchnera | 1 | 2007 | 1 | 0.020 |
Why?
| | Half-Life | 2 | 1999 | 143 | 0.020 |
Why?
| | Diet | 1 | 1995 | 1199 | 0.020 |
Why?
| | Base Sequence | 1 | 1991 | 2135 | 0.020 |
Why?
| | Humidity | 1 | 2007 | 48 | 0.020 |
Why?
| | Hypersensitivity, Immediate | 1 | 2006 | 43 | 0.020 |
Why?
| | Bacteriological Techniques | 1 | 2007 | 68 | 0.020 |
Why?
| | Anti-Bacterial Agents | 3 | 2007 | 1663 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 1991 | 2819 | 0.020 |
Why?
| | Weaning | 1 | 1986 | 48 | 0.020 |
Why?
| | Genome, Bacterial | 1 | 2007 | 134 | 0.020 |
Why?
| | Models, Molecular | 1 | 1991 | 1480 | 0.020 |
Why?
| | Sleep | 1 | 1991 | 676 | 0.020 |
Why?
| | Evaluation Studies as Topic | 1 | 1985 | 171 | 0.020 |
Why?
| | Chronic Disease | 2 | 2004 | 1705 | 0.020 |
Why?
| | Antibody Formation | 1 | 1987 | 288 | 0.020 |
Why?
| | Infant, Low Birth Weight | 1 | 1986 | 135 | 0.020 |
Why?
| | Nigeria | 1 | 2005 | 15 | 0.010 |
Why?
| | Acid-Base Equilibrium | 1 | 2005 | 27 | 0.010 |
Why?
| | Parainfluenza Virus 2, Human | 1 | 2004 | 3 | 0.010 |
Why?
| | Parainfluenza Virus 1, Human | 1 | 2004 | 3 | 0.010 |
Why?
| | Parainfluenza Virus 3, Human | 1 | 2004 | 5 | 0.010 |
Why?
| | Nasal Lavage Fluid | 1 | 2004 | 14 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2007 | 1269 | 0.010 |
Why?
| | Virus Cultivation | 1 | 2004 | 28 | 0.010 |
Why?
| | Adenoviruses, Human | 1 | 2004 | 26 | 0.010 |
Why?
| | Exocrine Glands | 1 | 2004 | 5 | 0.010 |
Why?
| | Basement Membrane | 1 | 2004 | 30 | 0.010 |
Why?
| | Risk | 1 | 1987 | 853 | 0.010 |
Why?
| | Ultraviolet Rays | 1 | 2007 | 384 | 0.010 |
Why?
| | Immunization Schedule | 1 | 1985 | 198 | 0.010 |
Why?
| | Body Temperature | 1 | 2005 | 212 | 0.010 |
Why?
| | Temperature | 1 | 2007 | 625 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2007 | 1020 | 0.010 |
Why?
| | Plasma Cells | 1 | 2004 | 65 | 0.010 |
Why?
| | Immunization | 1 | 1986 | 412 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2005 | 536 | 0.010 |
Why?
| | Cardiopulmonary Bypass | 1 | 2005 | 190 | 0.010 |
Why?
| | Survival Rate | 1 | 2007 | 1869 | 0.010 |
Why?
| | Escherichia coli | 1 | 2007 | 765 | 0.010 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 1999 | 3624 | 0.010 |
Why?
| | Carbon Dioxide | 1 | 2005 | 260 | 0.010 |
Why?
| | Esophagus | 1 | 2005 | 248 | 0.010 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2008 | 1356 | 0.010 |
Why?
| | Phenotype | 1 | 1991 | 3044 | 0.010 |
Why?
| | Lymphocytes | 1 | 2004 | 367 | 0.010 |
Why?
| | Eosinophils | 1 | 2004 | 323 | 0.010 |
Why?
| | Metacarpophalangeal Joint | 1 | 1980 | 13 | 0.010 |
Why?
| | Biopsy | 1 | 2004 | 1081 | 0.010 |
Why?
| | Polysaccharides, Bacterial | 1 | 2000 | 67 | 0.010 |
Why?
| | Medical Records | 1 | 2000 | 170 | 0.010 |
Why?
| | Nasal Decongestants | 1 | 1999 | 8 | 0.010 |
Why?
| | Placebos | 1 | 1999 | 201 | 0.010 |
Why?
| | Glutamate Decarboxylase | 1 | 1999 | 166 | 0.010 |
Why?
| | Insulin Antibodies | 1 | 1999 | 105 | 0.010 |
Why?
| | Otorhinolaryngologic Surgical Procedures | 1 | 1999 | 33 | 0.010 |
Why?
| | Injections, Intramuscular | 1 | 1999 | 116 | 0.010 |
Why?
| | C-Peptide | 1 | 1999 | 163 | 0.010 |
Why?
| | Triage | 1 | 2001 | 206 | 0.010 |
Why?
| | Bacteremia | 1 | 2000 | 190 | 0.010 |
Why?
| | Radiography, Thoracic | 1 | 1997 | 164 | 0.010 |
Why?
| | Combined Modality Therapy | 1 | 1999 | 1204 | 0.010 |
Why?
| | Recurrence | 1 | 1999 | 996 | 0.010 |
Why?
| | Physical Examination | 1 | 1997 | 233 | 0.010 |
Why?
| | Therapeutic Equivalency | 1 | 1995 | 20 | 0.010 |
Why?
| | Patient Selection | 1 | 1999 | 663 | 0.010 |
Why?
| | Diet Surveys | 1 | 1995 | 92 | 0.010 |
Why?
| | Evidence-Based Medicine | 1 | 1999 | 711 | 0.010 |
Why?
| | Random Allocation | 1 | 1995 | 343 | 0.010 |
Why?
| | Telephone | 1 | 1995 | 168 | 0.010 |
Why?
| | Marriage | 1 | 1995 | 113 | 0.010 |
Why?
| | Islets of Langerhans | 1 | 1999 | 790 | 0.010 |
Why?
| | Diagnosis, Differential | 1 | 1997 | 1416 | 0.010 |
Why?
| | Acetaminophen | 1 | 1994 | 243 | 0.010 |
Why?
| | Autoantibodies | 1 | 1999 | 1463 | 0.010 |
Why?
| | Tropical Climate | 1 | 1991 | 18 | 0.010 |
Why?
| | Pleura | 1 | 1991 | 22 | 0.010 |
Why?
| | Pharynx | 1 | 1991 | 57 | 0.010 |
Why?
| | Clinical Protocols | 1 | 1992 | 252 | 0.010 |
Why?
| | Emergency Service, Hospital | 1 | 2001 | 1901 | 0.010 |
Why?
| | Blood Glucose | 1 | 1999 | 2093 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 1997 | 3020 | 0.010 |
Why?
| | Insulin | 1 | 1999 | 2315 | 0.000 |
Why?
| | Monitoring, Physiologic | 1 | 1991 | 266 | 0.000 |
Why?
| | Injections, Subcutaneous | 1 | 1989 | 144 | 0.000 |
Why?
| | Antigens, Bacterial | 1 | 1989 | 119 | 0.000 |
Why?
| | Thorax | 1 | 1988 | 41 | 0.000 |
Why?
| | Sepsis | 1 | 1991 | 556 | 0.000 |
Why?
|
|
Simoes's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|